ArticleRSC advances2019

Discovery of potential therapeutic targets for non-small cell lung cancer using high-throughput metabolomics analysis based on liquid chromatography coupled with tandem mass spectrometry.

Hong-Dan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.